Economic evaluation of plerixafor for stem cell mobilization

Source:
NHS Economic Evaluation Database - NHS EED
Publication date:
08 May 2013

Abstract

Bibliographic details

Kymes SM, Pusic I, Lambert DL, Gregory M, Carson KR, DiPersio JF.  Economic evaluation of plerixafor for stem cell mobilization. American Journal of Managed Care 2012; 18(1): 33-41

Status

This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.

CRD summary

Indexing status

Subject indexing assigned by NLM

Index terms

Costs and Cost Analysis; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds /administration & dosage /economics /therapeutic use; Humans; Lymphoma, Non-Hodgkin /drug therapy; Markov Chains; Outcome Assessment (Health Care)